[HTML][HTML]Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020

…,G Ippolito, H Kunst, AMaryandyshev… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
Coronavirus disease has disrupted tuberculosis services globally. Data from 33 centers in 16
countries on 5 continents showed that attendance at tuberculosis centers was lower during …

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

S Borisov, E Danila, AMaryandyshev… - European …, 2019 - Eur Respiratory Soc
The World Health Organization (WHO) recommends that countries implement pharmacovigilance
and collect information on active drug safety monitoring (aDSM) and management of …

[HTML][HTML]Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

…, V Marchese, EM Robles, AMaryandyshev… - International journal of …, 2019 - Elsevier
The World Health Organization launched a global initiative, known as aDSM (active TB drug
safety monitoring and management) to better describe the safety profile of new treatment …

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study

…,S Tiberi,JW Alffenaar, AMaryandyshev2017 -欧盟欧洲……,r Respiratory Soc
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant
tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …

[HTML][HTML]Bedaquiline and delamanid combination treatment of 5 patients with pulmonary extensively drug-resistant tuberculosis

AMaryandyshev, E Pontali,S Tiberi… - Emerging infectious …, 2017 - ncbi.nlm.nih.gov
We report the experiences of 5 patients taking bedaquiline with delamanid in combination:
1 patient was cured; 3 culture converted, with 2 continuing and 1 changing therapy; and 1 …

Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery

…, BL Mastrapa, V Manfrin, S Manga, AMaryandyshev… - Journal of Infection, 2019 - Elsevier
Objectives No study evaluated the contribution of adjunctive surgery in bedaquiline-treated
patients. This study describes treatment outcomes and complications in a cohort of drug-…

[HTML][HTML]Risk factors for acquisition of drug resistance during multidrug-resistant tuberculosis treatment, Arkhangelsk Oblast, Russia, 2005–2010

…, I Tarasova, P Eliseev, AOMaryandyshev… - Emerging Infectious …, 2015 - ncbi.nlm.nih.gov
Acquired resistance to antituberculosis drugs decreases effective treatment options and the
likelihood of treatment success. We identified risk factors for acquisition of drug resistance …

[HTML][HTML]Epidemiological analyses of tuberculosis in Archangelsk, Russia and implementation of a rapid assay for detection of resistance in this high burden setting

PI Eliseev, AOMaryandyshev, EI Nikishova… - International Journal of …, 2013 - Elsevier
Background Tuberculosis (TB) is a major problem in Russia, particularly regarding multidrug-resistant
tuberculosis (MDR-TB). Rapid drug susceptibility testing methods are therefore …

Multidrug-resistant tuberculosis in children in northwest Russia: an observational cohort study

…, OM Mironuk, AOMaryandyshev- European …, 2016 - Eur Respiratory Soc
Multidrug-resistant tuberculosis in children in northwest Russia: an observational cohort study
| European Respiratory Society Skip to main content Main menu Home Current issue ERJ …

Bedaquiline (BQ)-containing regimen at the programmatic level for MDR-TB: preliminary results

…,G Sotgiu,S Tiberi,JW Alffenaar, AMaryandyshev… - 2017 - Eur Respiratory Soc
Introduction: Well designed studies on BQ used programmatically to treat M/XDR tuberculosis
(TB) are lacking. The aim of this study is to evaluate effectiveness and safety of BQ in a …